Inflammatory and Degenerative Muscle Disease

February 12, 2023 updated by: Huda Mahmoud Sayed Abdelal, Assiut University

Neurophysiological, Sonographical and Pathological Findings in Patients With Inflammatory Versus Degenerative Muscle Diseases

Correlation between clinical , ultrasonographical, neurophysiological and histopathological findings in muscle diseases of different etiologies.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Any patients with muscle disease of different etiologies aged from 18 years to 75 years, of both sex

Description

Inclusion Criteria:

  1. Muscle diseases of different etiologies.
  2. Any age.

Exclusion Criteria:

  1. Patient refuse to participate.
  2. The anatomy is altered due to severe trauma, tumor , or surgery.
  3. Severe deformity preventing examination.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
inflammatory muscle disease
Procedure: muscle biopsy
true cut needle biopsy
Other Names:
  • neurophysiology(nerve conduction,electromyography)
  • muscle ultrasound
degenerative muscle disease
Procedure: muscle biopsy
true cut needle biopsy
Other Names:
  • neurophysiology(nerve conduction,electromyography)
  • muscle ultrasound

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
microscopic picture of muscle in inflammatory and degenerative muscle disease
Time Frame: 1 year
true cut needle muscle biopsy is done to differentiate between inflammatory and degenerative muscle disease in microsopic picture
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
muscle ultrasound in inflammatory and degenerative muscle disease
Time Frame: 1 year
muscle ultrasound picture and dimensions in inflammatory and degenerative muscle disease
1 year
neurophysiology in inflammatory and degenerative muscle disease
Time Frame: 1 year
electromyography changes in inflammatory and degenerative muscle disease
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Assiut University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

April 1, 2023

Primary Completion (Anticipated)

March 31, 2024

Study Completion (Anticipated)

May 28, 2024

Study Registration Dates

First Submitted

January 24, 2023

First Submitted That Met QC Criteria

February 12, 2023

First Posted (Estimate)

February 22, 2023

Study Record Updates

Last Update Posted (Estimate)

February 22, 2023

Last Update Submitted That Met QC Criteria

February 12, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • muscle disease neurophysiology

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe